Notes

Sep8~04:02UTC node /app/agent/dist/backtest.js --symbols EGTX.ST --strategy sma-cross --fast10 --slow50 --days1700 returned0bars/0trades/nullwinrate. No test evidence; zero reportedreturn means missingdata,not cash benchmark success. Foreign instrument ordereligibility remains unverified; no order endpoint used toprobe. https://runway.adityaperswal.workers.dev/data/stock-bars

{"ma":50,"hold":10,"slippage":0.005,"split":"holdout","sample":56,"return_pct":-62.9913394025096,"drawdown_pct":66.27759014432232,"win_rate_pct":37.5,"avg_win_pct":6.847408926441736,"avg_loss_pct":6.559546001076525,"mean_pct":-1.531937903257176,"mean_CI_pct":[-3.275298733191116,0.2713000007605148],"mechanical_quarter_Kelly":0}; not FDA-event evidence; frozen note921, adjustedOHLC training2021–24/holdout2025–Sep4 2026; costs modeled not venuevalidated. https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST

{"ma":50,"hold":10,"slippage":0.005,"split":"train","sample":89,"return_pct":-92.08374649762945,"drawdown_pct":93.64209006891123,"win_rate_pct":33.70786516853933,"avg_win_pct":7.891718572003155,"avg_loss_pct":7.762828360528748,"mean_pct":-2.486014787765186,"mean_CI_pct":[-4.132089606035996,-0.7962009414700268],"mechanical_quarter_Kelly":0}; not FDA-event evidence; frozen note921, adjustedOHLC training2021–24/holdout2025–Sep4 2026; costs modeled not venuevalidated. https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST

{"ma":50,"hold":10,"slippage":0.0025,"split":"holdout","sample":56,"return_pct":-51.03253789539989,"drawdown_pct":56.37302168652274,"win_rate_pct":37.5,"avg_win_pct":7.382991622598042,"avg_loss_pct":6.091166928662465,"mean_pct":-1.0383574719397752,"mean_CI_pct":[-2.7756806886193144,0.8046420362956158],"mechanical_quarter_Kelly":0}; not FDA-event evidence; frozen note921, adjustedOHLC training2021–24/holdout2025–Sep4 2026; costs modeled not venuevalidated. https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST

{"ma":50,"hold":10,"slippage":0.0025,"split":"train","sample":89,"return_pct":-87.64668385287895,"drawdown_pct":91.02463331274096,"win_rate_pct":33.70786516853933,"avg_win_pct":8.432535968572049,"avg_loss_pct":7.3004808542217985,"mean_pct":-1.9972167566508392,"mean_CI_pct":[-3.6573313440986057,-0.278037682237709],"mechanical_quarter_Kelly":0}; not FDA-event evidence; frozen note921, adjustedOHLC training2021–24/holdout2025–Sep4 2026; costs modeled not venuevalidated. https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST

{"c": 15.19, "o": 16.24, "r": -0.1818825752241307, "g": -0.11504255709828039, "i": -0.06684001812585033, "threshold": 0.054439427431889405, "base": 0.7708881970181529, "clip": 0.5162815974145809, "rv60": 0.4727034501285257, "date": "2026-09-04 04:00:00+00:00", "jump": true, "ATR14": 0.9588285714285708, "EMA20": 16.45525657110016, "EMA60": 14.234582202761898, "RSI14": 45.265674487833046} https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=PATH&timeframe=1Day&adjustment=all&feed=sip

Python derivedSep8; assumptions and limitations in paired analysis. {"runway_months_CFO_capex":11.751552795031056,"runway_with_Q2_debt_lease":10.780626780626779,"Q2monthly_operating_investing_burn":32.199999999999996,"cash_after_one_same_burn_quarter":273.09999999999997,"raise_fee_pct":5.4,"ordinary_share_growth_pct":17.659702432622492,"ordinary_equity_MSEK":3580.0936248000003,"annualized_Q2_sales_MSEK":69.6,"price_sales_runrate":51.43812679310346,"PRV_retained_USDm_scenarios":[50,75,100],"risk_limit_USD":8.5099,"max_notional_at30pct_gap":28.366333333333333,"max_notional_at50pct_gap":17.0198} https://attachment.news.eu.nasdaq.com/aa8bae6e3da62b95404c23eb6ec2cc25a

Python derivedSep8; assumptions and limitations in paired analysis. {"paths":100000,"training_days":836,"mean_pct":-1.2141017487197086,"win_rate_pct":37.666,"p05_pct":-5.698314298935282,"p95_pct":6.18360592826479,"stop_pct":62.245,"target_pct":37.57,"time_pct":0.185,"stop_SEK":7.344285488128662,"target_SEK":8.233571290969849,"net_RR":1.170029807011967,"full_fund_30pct_gap_loss_USD":14.741999999999999,"full_fund_50pct_gap_loss_USD":24.57} https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST

Python derivedSep8; assumptions and limitations in paired analysis. {"rows":1256,"last_date":"2026-09-04","close":7.699999809265137,"SMA50":6.7509999847412105,"ret20_pct":8.757060624861435,"ATR14":0.3557143211364746,"range20":0.31800003051757814,"vol20_pct":41.06149985866022,"median_volume20":678731.5,"low20":6.730000019073486,"high20":8.199999809265137,"worst_gap_pct":-26.838236497210268,"worst_gap_date":"2023-05-24","autocorr1":0.04602431271758511} https://query1.finance.yahoo.com/v8/finance/chart/EGTX.ST

Sep3issuer retainsSep28PDUFA; CantorfiresideSep11 09:10–09:40EDT andMorganStanleySep16 13:50–14:20EDT, not firstnewdata promises. Aladoteprogramparked; RTHbeta distinct. Sep4notice https://mfn.se/a/egetis-therapeutics/emcitate-r-tiratricol-presentations-at-eta-and-espe-congresses-in-september-2026 listsETA TriacII Sep5poster/Sep7oral,ReTRIACtSep6oral; ESPEReTRIACtSep8poster,dateonly. Conferenceabstractalreadypublic; presentationdaynotuncontaminatedreadout. CollectedSep8~04:06UTC. https://www.egetis.com/mfn_news/egetis-therapeutics-to-participate-in-upcoming-investor-conferences-in-september/

{"n": 16, "clip_minus_base_qlike_mean": 0.0034810283898417393, "iid_bootstrap_95ci": [-0.00473103716094166, 0.015646080037962428], "models": {"base": {"qlike": 0.14625774380908818, "realized_forecast_ratio": 0.9364766336069992}, "clip": {"qlike": 0.14973877219892995, "realized_forecast_ratio": 0.9629372972762519}, "rv60": {"qlike": 0.10722310495122679, "realized_forecast_ratio": 0.8897788065264571}}} https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=PATH&timeframe=1Day&adjustment=all&feed=sip

{"n": 100, "clip_minus_base_qlike_mean": -0.0561488765400711, "iid_bootstrap_95ci": [-0.11395984689211344, -0.010431857087857422], "models": {"base": {"qlike": 0.7207904462559999, "realized_forecast_ratio": 1.0388192066438928}, "clip": {"qlike": 0.6646415697159288, "realized_forecast_ratio": 1.277841774931403}, "rv60": {"qlike": 0.68903234047545, "realized_forecast_ratio": 1.0297951279848454}}} https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=PATH&timeframe=1Day&adjustment=all&feed=sip

{"sip_n": 1351, "iex_n": 1349, "start": "2021-04-21 04:00:00+00:00", "end": "2026-09-04 04:00:00+00:00", "sip_next": null, "duplicates": 0, "bad_ohlc": 0, "iex_last_close": 15.2, "sip_last_close": 15.19}; adjusted all daily bars retrieved Sep8; IEX is a venue subset, not consolidated opening auction. { "negative": { "n": 10, "post20_base_ratio": 0.49155405963385096, "post20_clip_ratio": 0.9710959621096712, "mean_future_vol": 0.6271115315274932 }, "exclude_largest": { "n": 20, "post20_base_ratio": 0.9221755903738054, "post20_clip_ratio": 1.2130085630216034, "mean_future_vol": 0.6861392081716621 }, "holdout_circular3block_CI": [ -0.0026657089627016317, 0.011285865830610652 ], "missing_iex_dates": [ "2021-10-25 04:00:00+00:00", "2022-03-08 05:00:00+00:00" ] } https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=PATH&timeframe=1Day&adjustment=all&feed=sip

Sep8~04:03UTC request14fixedsymbols EWA EWC EWG EWH EWJ EWL EWT EWU EWW EWY EWZ FXI EFA SPY;1Day,SIP,adjustmentall,start2007-01-01,end2026-09-05,ascending,10000pagination. All14return2684identicaltradingdates2016-01-04..2026-09-04;37576bars,0duplicates/0OHLCfailures,noimputedbars. Actualtrain2016-2020;pre2016missing. APIall includescorporateactionadjustment; adjustedOHLCnotexplicitcashdividendaccounting. FixedsurvivingETFpaneldoesnotprovehistoricaluniversecompleteness. Rawfileslocalresearch/<symbol>.json;fetch.pyreproducible,providerlaterrevisionspossible. https://runway.adityaperswal.workers.dev/data/stock-bars ; https://docs.alpaca.markets/us/v1.1/reference/stockbars

Miwa2019 primary journal abstract retrievedsearchSep8 reports subsequent-week stock reversal concentrated after intraday returns rather than overnight returns, stronger illiquid/volatile conditions. Fullpaperopen403; onlyabstractverified,noeffectsizeborrowed. Motivates frozenUS-sessionETFsignaldiagnostic, not established transfer acrossforeignmarketclocks. This is third independent research team, not independent confirmationofAQR'scostestimates. https://doi.org/10.1142/S2010139219500022

Registry sponsor-submitted updatedApr8 2026, fetchedSep8. Actual enrollment20, primarycompletionJul22 2025/studycompletionSep3 2025; two current primary endpoints, no resultsSection. Abstract15randomized plausiblysubsetof20enrolled, but participantflow absent; do not assert5excluded reasons. SponsorNov14 describes SAPrevisionafterOctmeeting; registry completionpredatesmeeting. Need versionedSAP/unblindingtimeline to assess prospective status; currentregistrycannotestablish it. No allegationofmisconduct or approvalprobability from this chronology. https://clinicaltrials.gov/api/v2/studies/NCT05579327